Assessment of serum levels resistin in girls with anorexia nervosa. Part I. Relationship between resistin and body mass index

Neuroendocrinology Letters

Volumn 32, Issue 5, 2011, Pages 691-696

  Ziora, Katarzyna ^a   Oświȩcimska, Joanna ^a   Świȩtochowska, Elzbieta ^a   Ostrowska, Zofia ^a   Stojewska, Małgorzata ^a   Gorczyca, Piotr ^a   Rojewska, Katarzyna ^a   Ziora Jakutowicz, J Karolina ^b   Szczepańska, Maria ^a   Ziora, Dariusz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Adolescents; Anorexia nervosa; Body mass index; Eating disorders; Girls; Obesity; Resistin

Indexed keywords

RESISTIN;

ADOLESCENT; ANOREXIA NERVOSA; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; EATING DISORDER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBESITY;

EID: 84857436607     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorder (DSM IV). Washington DC: APA.
2. Anderlová K, Křemen J, Doležalova R, Housová J, Haluzíkova D, Kunešova M et al. (2006). The influence of very-low-calorie diet on serum leptin, soluble receptor, adiponectin and resistin levels in obese women. Physiol Res. 55: 277-283.
3. Banerjee RR., Lazar MA (2003). Resistin: molecular history and prognosis. J Mol Med. 81: 218-226. (Pubitemid 36578920)
4. Brichard SM, Delporte ML, Lambert M (2003). Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res. 35: 337-342. (Pubitemid 37102677)
5. Dolezalova R, Lacinova Z, Dolinkova M, Kleiblova P, Haluzikova D, Housa D, et al. (2007). Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Clin Endocrinol (Oxf). 67: 674-678. (Pubitemid 47620431)
6. Dostalová I, Kunešová M, Dušková J, Papežova H, Nedvídková J. (2006). Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition. 22: 977-983.
7. Dostalová., Smitka K, Papežova H, Kvasničková H, Nedvídková J (2007). Increased insulin sensitivity in patients with anorexia nervosa: the role of adipocytokines. Physiol Res. 56: 587-594.
8. Frisch RE, Revelle R (1970). Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science. 169: 397-399.
9. Gerber M, Böttner A, Seidel B, Lammert A, Bär J, Schuster E, et al. (2005). Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab. 90: 4503-4509. (Pubitemid 41159333)
10. Gerstmayer B, Küsters D, Gebel S, Müller T, VanMiert E, Hofmann K, et al. (2003). Identification of RELM gamma, a novel resistin-like molecule with a distinct expression pattern. Genomics. 81: 588-595. (Pubitemid 36627503)
11. Hebebrand J, Muller TD, Holtkamp K, Herpertz-Dahlmann B (2007). The role of leptin in anorexia nervosa: clinical implications. Mol Psych. 12: 23-35. (Pubitemid 44973660)
12. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, et al. (2000). FIZZI, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19: 4046-4055. (Pubitemid 30608543)
13. Housová J, Anderlová K, Křížová J, Haluzíková D, Křemen J, Kumštyřová T, et al. (2005). Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab. 90: 1366-1370. (Pubitemid 40463989)
14. Kim KH, Lee K, Moon YS, Sul HS (2001). A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 276: 11252-11256. (Pubitemid 38089312)
15. Koerner A, Kratzsch J, Kiess W (2005). Adipocytokines: leptin - the classical. Resistin - the controversial, adiponectin - the promising, and more to come. Best Pract Res Clin Endocrinol Metab. 19(4): 525-546. (Pubitemid 41819217)
16. Kopp W, Blum WF, von Prittwitz S, Ziegler A, Lübbert H, Emons G, et al. (1997). Low leptin levels predict amenorrhea in undeweight and eating disordered females. Mol Psychiatry. 2: 335-340. (Pubitemid 27450317)
17. Körner A, Blüher S, Kapellen T, Garten A, Klammt J, Kratzsh J, et al. (2005). Obesity in childhood and adolescence: a review in the interface between adipocyte physiology and clinical challenges. Hormones. 4(4): 189-199
18. Křížova J, Dolinková M, Lacinová Z, Sulek S, Doležalová R, Housová J, et al. (2008). Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype. Physiol Res. 57(4): 539-546.
19. Kulik-Rechberger B, Rechberger T (2003). Stȩżenie leptyny i rezystyny w surowicy krwi dziewcza̧t w okresie pokwitania. Gin Pol. 74: 973-978.
20. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA (2004). An inflammatory cascade leading to hyperresistinemia in humans. Public Library of Science Medicine. 1: 45.
21. Lewandowski KC, Szosland K, O'Callaghan C, Tan BK, Randeva HS, Lewinski A (2005). Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices. Mol Genet Metab. 85: 61-69. (Pubitemid 40603026)
22. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, et al. (2006). Changes and relations od circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes. 114: 544-548. (Pubitemid 46087259)
23. Palczewska I, Niedźwiecka Z (2001). Wskaźniki rozwoju somatycznego dzieci i młodzieży warszawskiej. Med Wieku Rozw. 2 (Supl.1) 5: 39.
24. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, et al. (2003). Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 300: 472-476. (Pubitemid 38375833)
25. Rea R, Donnelly R (2004). Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity? Diabetes Obes Metab. 6: 163-170. (Pubitemid 38559695)
26. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, et al. (2001). Resistin/Fizz3 expression relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes. 50: 2199-2202. (Pubitemid 33641901)
27. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. (2001). The hormone resistin links obesity to diabetes. Nature. 409: 307-312. (Pubitemid 32151228)
28. nd edn. Oxford. Blackwell.
29. Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, et al. (2001). Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem. 276: 25651-25653.
30. Yannakoulia M, Yiannakouris N, Blüher S, Matalas AL, Klimis-Zacas D, Mantzoros S (2003). Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab. 88: 1730-1736. (Pubitemid 36623396)